Marie Théaudin

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


101 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2003 |
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.
Vicino A., Hottinger A.F., Latifyan S., Boughdad S., Becce F., Prior J.O., Kuntzer T., Brouland J.P., Dunet V., Obeid M. et al., 2024/04. Journal of neurology, 271 (4) pp. 1947-1958. Peer-reviewed.
 
Diffuse and acute pain syndrome in a 60-year-old woman.
Baumgartner T., Théaudin M., Loser V., 2024/03/19. Practical neurology, 24 (2) pp. 169-172. Peer-reviewed.
 
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
Jeantin L., Januel E., Labauge P., Maillart E., de Seze J., Zéphir H., Pelletier J., Kerschen P., Biotti D., Heinzlef O. et al., 2024/03. Multiple sclerosis, 30 (3) pp. 381-395. Peer-reviewed.
 
Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy.
Afanasiev V., Tsouni P., Kuntzer T., Cairoli A., Delmont E., Vallat J.M., Devaux J., Théaudin M., 2024/03. Journal of the peripheral nervous system, 29 (1) pp. 116-119. Peer-reviewed.
False Negative 99mTc-DPD Scintigraphy in pVal50Met (Val30Met) Hereditary Transthyretin Amyloidosis.
Redzepi B., Kamani C.H., Maurizi N., Théaudin M., Prior J., Monney P., 2024/02. CJC open, 6 (2Part A) pp. 118-121. Peer-reviewed.
 
Neurologie: ce qui a changé en 2023 [Neurology: what's new in 2023]
Pizzarotti B., Buhler-Heintze A., Allali G., Rouaud O., Bally J., Michel P., Hirt L., Théaudin M., Pot Kreis C., Ryvlin P. et al., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 72-75. Peer-reviewed.
 
Patisiran exposure in early pregnancy: a case report.
Loser V., Baumgartner T., Legardeur H., Panchaud A., Théaudin M., 2024. Therapeutic advances in neurological disorders, 17 p. 17562864241239755. Peer-reviewed.
SORD-related peripheral neuropathy in a French and Swiss cohort: Clinical features, genetic analyses, and sorbitol dosages.
Pons N., Fernández-Eulate G., Pegat A., Théaudin M., Guieu R., Ripellino P., Devedjian M., Mace P., Masingue M., Léonard-Louis S. et al., 2023/07. European journal of neurology, 30 (7) pp. 2001-2011. Peer-reviewed.
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex.
Vicino A., Cochet S., Pistocchi S., Conrad C., Ribi C., Du Pasquier R., Brouland J.P., Théaudin M., 2023/06. Journal of the peripheral nervous system, 28 (2) pp. 266-268. Peer-reviewed.
Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.
Mathias A., Pantazou V., Perriot S., Canales M., Jones S., Oberholster L., Moulin M., Fenwick C., Bernard-Valnet R., Théaudin M. et al., 2023/03. Neurology: Neuroimmunology & Neuroinflammation, 10 (2) pp. e200084. Peer-reviewed.
 
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience.
Loser V., Benkert P., Vicino A., Lim Dubois Ferriere P., Kuntzer T., Pasquier J., Maceski A., Kuhle J., Theaudin M., 2023/03. Journal of the peripheral nervous system, 28 (1) pp. 86-97. Peer-reviewed.
 
Neurologie : ce qui a changé en 2022 [Neurology: what's new in 2022]
Bouvy C., Caranzano L., Allali G., Bally J., Benninger D., Beuchat I., Castro Jimenez M., Di Virgilio G., Hirt L., Michel P. et al., 2023/01/18. Revue medicale suisse, 19 (809-10) pp. 42-45. Peer-reviewed.
 
Clinical Reasoning: A 39-Year-Old Man With Asymmetric Distal Weakness and Loss of Sensitivity.
Loser V., Blanchard G., Guenova E., Théaudin M., Vicino A., 2023/01/10. Neurology, 100 (2) pp. 88-93. Peer-reviewed.
 
Targeted dorsal root entry zone stimulation alleviates pain due to meralgia paresthetica.
Aureli V., Vat M., Hankov N., Théaudin M., Ravier J., Becce F., Demesmaeker R., Asboth L., Courtine G., Bloch J., 2022/12/07. Journal of neural engineering, 19 (6). Peer-reviewed.
 
Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis.
Borrelli S., Mathias A., Goff G.L., Pasquier R.D., Théaudin M., Pot C., 2022/07. Multiple sclerosis and related disorders, 63 p. 103887. Peer-reviewed.
Discussing Challenges in Diagnosis of Tuberculous Meningitis and Neurosarcoidosis.
Santos A., Desgranges F., Jovanovic M., Anichini A., Kritikos A., Dunet V., Brouland J.P., Théaudin M., Pot C., Du Pasquier R. et al., 2022/05. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 49 (3) pp. 445-451. Peer-reviewed.
Crampes et fasciculations : est-ce une sclérose latérale amyotrophique ? [Cramps and fasciculations: is it amyotrophic lateral sclerosis?]
Hübers A., Fayolle D., Ochsner F., Echaniz-Laguna A., Magy L., Vicino A., Théaudin M., 2022/04/27. Revue medicale suisse, 18 (779) pp. 790-793. Peer-reviewed.
Crampes musculaires [Muscle cramps]
Fayolle D., Théaudin M., Ochsner F., Echaniz-Laguna A., Magy L., Vicino A., Hübers A., 2022/04/27. Revue medicale suisse, 18 (779) pp. 785-788. Peer-reviewed.
Diagnostiquer une neuropathie des petites fibres [Small fiber neuropathy diagnosis]
Théaudin M., Ochsner F., Adam C., Echaniz-Laguna A., Magy L., Fayolle D., Vicino A., Hübers A., Pereon Y., 2022/04/27. Revue medicale suisse, 18 (779) pp. 803-807. Peer-reviewed.
Douleurs et faiblesse de l’épaule neurologique : attitudes pratiques [Neurological shoulder pain and weakness : practical attitudes]
Ochsner F., Kuntzer T., Vicino A., Hübers A., Fayolle D., Echaniz-Laguna A., Magy L., Théaudin M., Tatu L., 2022/04/27. Revue medicale suisse, 18 (779) pp. 794-798. Peer-reviewed.
Maladies musculaires de l’adulte : quand évoquer le diagnostic ? [Muscle disease in the adults: when to suspect it?]
Vicino A., Fayolle D., Ochsner F., Echaniz-Laguna A., Magy L., Hübers A., Théaudin M., 2022/04/27. Revue medicale suisse, 18 (779) pp. 799-802. Peer-reviewed.
Qu’avons-nous compris en 20 ans sur la polyradiculoneuropathie inflammatoire démyélinisante chronique ? [What have we learned about chronic inflammatory demyelinating polyradiculoneuropathyin the last twenty years ?]
Magy L., Echaniz-Laguna A., Fayolle D., Hübers A., Ochsner F., Vicino A., Théaudin M., 2022/04/27. Revue medicale suisse, 18 (779) pp. 808-812. Peer-reviewed.
Traiter les neuropathies héréditaires : un rêve qui devient réalité ? [Treating hereditary neuropathies : a dream come true?]
Echaniz-Laguna A., Magy L., Vicino A., Fayolle D., Hübers A., Ochsner F., Théaudin M., 2022/04/27. Revue medicale suisse, 18 (779) pp. 813-816. Peer-reviewed.
Neurologie [Neurology : what's new in 2021]
Vicino A., Allali G., Bally J., Castro Jimenez M., Chiabotti Salvioni P., Hirt L., Hottinger A., Michel P., Novy J., Pot Kreis C. et al., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 51-55. Peer-reviewed.
Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN β-1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis.
Cisarovsky C., Théaudin M., Bart P.A., Stalder G., Alberio L., 2022. Case reports in hematology, 2022 p. 2767031. Peer-reviewed.
 
Unusual brainstem and spine involvement in post-transplant lymphoproliferative disease.
Vicino A., Perrenoud M.P., Yersin E., Dunet V., Théaudin M., 2021/12. Revue neurologique, 177 (10) pp. 1303-1305. Peer-reviewed.
Management of transthyretin amyloidosis.
Condoluci A., Théaudin M., Schwotzer R., Pazhenkottil A.P., Arosio P., Averaimo M., Bacher U., Bode P., Cavalli A., Dirnhofer S. et al., 2021/10/11. Swiss medical weekly, 151 pp. w30053. Peer-reviewed.
 
Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a "common" first line treatment.
Pantazou V., Du Pasquier R., Pot C., Le Goff G., Théaudin M., 2021/10. Revue neurologique, 177 (8) pp. 935-940. Peer-reviewed.
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
Maggi P., Kuhle J., Schädelin S., van der Meer F., Weigel M., Galbusera R., Mathias A., Lu P.J., Rahmanzadeh R., Benkert P. et al., 2021/08/10. Neurology, 97 (6) pp. e543-e553. Peer-reviewed.
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.
Sormani M.P., Salvetti M., Labauge P., Schiavetti I., Zephir H., Carmisciano L., Bensa C., De Rossi N., Pelletier J., Cordioli C. et al., 2021/08. Annals of clinical and translational neurology, 8 (8) pp. 1738-1744. Peer-reviewed.
 
Nonsystemic vasculitic neuropathy: Presentation and long-term outcome from a French cohort of 50 patients.
Quirins M., Théaudin M., Cohen-Aubart F., Créange A., Mouthon L., Genty S., Kahn J.E., Bérezné A., Rigolet A., Adams D. et al., 2021/08. Autoimmunity reviews, 20 (8) p. 102874. Peer-reviewed.
 
Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatment.
Pantazou V., Pot C., Du Pasquier R., Le Goff G., Théaudin M., 2021/06. Multiple sclerosis and related disorders, 51 p. 102918. Peer-reviewed.
 
The central vein sign in multiple sclerosis patients with vascular comorbidities.
Guisset F., Lolli V., Bugli C., Perrotta G., Absil J., Dachy B., Pot C., Théaudin M., Pasi M., van Pesch V. et al., 2021/06. Multiple sclerosis, 27 (7) pp. 1057-1065. Peer-reviewed.
 
Pregnancy outcome following first-trimester exposure to fingolimod: A collaborative ENTIS study.
Pauliat E., Onken M., Weber-Schoendorfer C., Rousson V., Addor M.C., Baud D., Théaudin M., Diav-Citrin O., Cottin J., Agusti A. et al., 2021/03. Multiple sclerosis, 27 (3) pp. 475-478. Peer-reviewed.
Neurologie [Recent Advances in Neurology]
Anichini A., Salvioni Chiabotti P., Bally J., Castro Jimenez M., Démonet J.F., Di Virgilio G., Hirt L., Hottinger A., Kuntzer T., Michel P. et al., 2021/01/27. Revue medicale suisse, 17 (723) pp. 196-200. Peer-reviewed.
 
First-ever treatment in multiple sclerosis.
Pantazou V., Pot C., Du Pasquier R., Le Goff G., Théaudin M., 2021. Revue neurologique, 177 (1-2) pp. 93-99. Peer-reviewed.
 
Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis.
Schwotzer R., Flammer A.J., Gerull S., Pabst T., Arosio P., Averaimo M., Bacher V.U., Bode P., Cavalli A., Concoluci A. et al., 2020/11/30. Swiss medical weekly, 150 pp. w20364. Peer-reviewed.
 
Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: An International Multicenter 3T MRI Study.
Maggi P., Sati P., Nair G., Cortese ICM, Jacobson S., Smith B.R., Nath A., Ohayon J., van Pesch V., Perrotta G. et al., 2020/11. Annals of neurology, 88 (5) pp. 1034-1042. Peer-reviewed.
 
ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis.
Horisberger A., Pantazou V., Cuendet G., Ribi C., Dunet V., Théaudin M., 2020/10. Multiple sclerosis, 26 (12) pp. 1599-1602. Peer-reviewed.
Selective inhibition of anti-MAG IgM autoantibody binding to myelin by an antigen-specific glycopolymer.
Aliu B., Demeestere D., Seydoux E., Boucraut J., Delmont E., Brodovitch A., Oberholzer T., Attarian S., Théaudin M., Tsouni P. et al., 2020/09. Journal of neurochemistry, 154 (5) pp. 486-501. Peer-reviewed.
 
Cerebral Computed Tomography Scan Demonstrating Ischemic Stroke in a Filly After Intravenous Antibiotic Administration.
Saliou G., d'Ablon X., Théaudin M., Saliou T., Bourassi S., 2020/05. Journal of equine veterinary science, 88 p. 102953. Peer-reviewed.
 
Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins
Kouton Ludivine, Boucraut José, Devaux Jérome, Rajabally Yusuf A., Adams David, Antoine Jean Christophe, Bourdain Frédéric, Brodovitch Alexandre, Camdessanché Jean-Philippe, Cauquil Cécile et al., 2020/04. Clinical Neurophysiology, 131 (4) pp. 921-927.
 
The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.
Maggi P., Absinta M., Sati P., Perrotta G., Massacesi L., Dachy B., Pot C., Meuli R., Reich D.S., Filippi M. et al., 2020/04. Multiple sclerosis, 26 (4) pp. 421-432. Peer-reviewed.
 
Human Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis Prognosis
Lysandropoulos Andreas P., Perrotta Gaetano, Billiet Thibo, Ribbens Annemie, Du Pasquier Renaud, Pot Caroline, Maggi Pietro, Théaudin Marie, 2020/03. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 47 (2) pp. 189-196.
 
Ulnar neuropathy at the elbow: Reappraisal of the wrist-upper arm latency difference between ulnar and median nerves.
Di Virgilio G., Grapperon A.M., Fayerstein J., Goudot M., Nollet S., Ochsner F., Théaudin M., Truffert A., Tsouni P., Vial C. et al., 2020/02. Clinical neurophysiology, 131 (2) pp. 372-376. Peer-reviewed.
Neurologie [Neurology 2019]
Perrenoud M., Pantazou V., Michel P., Hirt L., Ryvlin P., Theaudin M., Rouaud O., Benninger D., Novy J., Rossetti A.O. et al., 2020/01/15. Revue medicale suisse, 16 (676-7) pp. 68-71. Peer-reviewed.
RimNet: A deep 3D multimodal MRI architecture for paramagnetic rim lesion assessment in multiple sclerosis.
Barquero G., La Rosa F., Kebiri H., Lu P.J., Rahmanzadeh R., Weigel M., Fartaria M.J., Kober T., Théaudin M., Du Pasquier R. et al., 2020. NeuroImage. Clinical, 28 p. 102412. Peer-reviewed.
 
Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination.
Fargeot G., Viala K., Theaudin M., Labeyrie M.A., Costa R., Léger J.M., Adams D., Vandendries C., Labeyrie C., 2019/04. European journal of neurology, 26 (4) pp. 631-638. Peer-reviewed.
 
Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas.
Théaudin M., Lozeron P., Algalarrondo V., Lacroix C., Cauquil C., Labeyrie C., Slama M.S., Adam C., Guiochon-Mantel A., Adams D. et al., 2019/03. European journal of neurology, 26 (3) pp. 497-e36. Peer-reviewed.
Marathons and myasthenia gravis: a case report.
Birnbaum S., Sharshar T., Eymard B., Theaudin M., Portero P., Hogrel J.Y., 2018/09/18. BMC neurology, 18 (1) p. 145. Peer-reviewed.
 
Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy
Lozeron Pierre, Mariani Louise-Laure, Dodet Pauline, Beaudonnet Guillemette, Théaudin Marie, Adam Clovis, Arnulf Bertrand, Adams David, 2018/07/10. Neurology, 91 (2) pp. e143-e152.
 
Neurologie [Neurology]
Chopard I., Benninger D., Demonet J.F., Du Pasquier R., Hirt L., Kuntzer T., Michel P., Nater B., Novy J., Rossetti A. et al., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 58-61. Peer-reviewed.
 
Expression of Yo Antigen in a Prostatic Adenocarcinoma.
Rosine N., Chrétien P., Adam C., Beaudonnet G., Not A., Drai J., Vahedi K., Cauquil C., Theaudin M., 2017/03. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 44 (2) pp. 221-223. Peer-reviewed.
 
Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation.
Algalarrondo V., Antonini T., Théaudin M., Chemla D., Benmalek A., Lacroix C., Castaing D., Cauquil C., Dinanian S., Eliahou L. et al., 2016/12. JACC. Cardiovascular imaging, 9 (12) pp. 1432-1441. Peer-reviewed.
 
Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?
Adams D., Beaudonnet G., Adam C., Lacroix C., Théaudin M., Cauquil C., Labeyrie C., 2016/10. Revue neurologique, 172 (10) pp. 645-652. Peer-reviewed.
 
Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?
Lozeron P., Ribrag V., Adams D., Brisset M., Vignon M., Baron M., Malphettes M., Theaudin M., Arnulf B., Kubis N., 2016/09. Journal of neurology, 263 (9) pp. 1761-1770. Peer-reviewed.
 
Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy.
Rousseau A., Cauquil C., Dupas B., Labbé A., Baudouin C., Barreau E., Théaudin M., Lacroix C., Guiochon-Mantel A., Benmalek A. et al., 2016/09/01. JAMA ophthalmology, 134 (9) pp. 983-989. Peer-reviewed.
 
Vessel Wall Contrast Enhancement on Magnetic Resonance Imaging May Be Suggestive for Future Development of Further Arterial Changes
Saliou G., Tardieu M., Theaudin M., Power S., Deiva K., 2016/09. Can J Neurol Sci, 43 (5) pp. 728-30. Peer-reviewed.
 
Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P., Not A., Theaudin M., Denier C., Masnou P., Sarov M., Adam C., Cauquil C., Adams D., 2016/05. Muscle & nerve, 53 (5) pp. 683-689. Peer-reviewed.
 
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Barbin L., Rousseau C., Jousset N., Casey R., Debouverie M., Vukusic S., De Sèze J., Brassat D., Wiertlewski S., Brochet B. et al., 2016/02/23. Neurology, 86 (8) pp. 771-778. Peer-reviewed.
 
In multiple sclerosis anxiety, not depression, is related to gender.
Théaudin M., Romero K., Feinstein A., 2016/02. Multiple sclerosis, 22 (2) pp. 239-244. Peer-reviewed.
 
Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies.
Lozeron P., Lacour M.C., Vandendries C., Théaudin M., Cauquil C., Denier C., Lacroix C., Adams D., 2016/01/15. Journal of the neurological sciences, 360 pp. 170-175. Peer-reviewed.
 
TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.
Adams D., Cauquil C., Labeyrie C., Beaudonnet G., Algalarrondo V., Théaudin M., 2016. Expert opinion on pharmacotherapy, 17 (6) pp. 791-802. Peer-reviewed.
 
Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome.
Théaudin M., Elefant E., Senat M.V., 2015/12/15. Journal of the neurological sciences, 359 (1-2) pp. 211-212. Peer-reviewed.
 
Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Mariani L.L., Lozeron P., Théaudin M., Mincheva Z., Signate A., Ducot B., Algalarrondo V., Denier C., Adam C., Nicolas G. et al., 2015/12. Annals of neurology, 78 (6) pp. 901-916. Peer-reviewed.
 
Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis.
Algalarrondo V., Antonini T., Théaudin M., Ducot B., Lozeron P., Chemla D., Benmalek A., Lacroix C., Azoulay D., Castaing D. et al., 2015/11/10. Journal of the American College of Cardiology, 66 (19) pp. 2154-2156. Peer-reviewed.
 
Extracranial vertebral artery dissection in children: natural history and management.
Simonnet H., Deiva K., Bellesme C., Cabasson S., Husson B., Toulgoat F., Théaudin M., Ducreux D., Tardieu M., Saliou G., 2015/07. Neuroradiology, 57 (7) pp. 729-738. Peer-reviewed.
 
Depression and Multiple Sclerosis: Clinical Aspects, Epidemiology, and Management
Théaudin Marie, Feinstein Anthony, 2015. pp. 17-25 dans Neuropsychiatric Symptoms of Inflammatory Demyelinating Diseases, Springer International Publishing.
 
Current and future treatment of amyloid neuropathies.
Adams D., Cauquil C., Theaudin M., Rousseau A., Algalarrondo V., Slama M.S., 2014/12. Expert review of neurotherapeutics, 14 (12) pp. 1437-1451. Peer-reviewed.
 
Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, "EdAmyl".
Théaudin M., Cauquil C., Antonini T., Algalarrondo V., Labeyrie C., Aycaguer S., Clément M., Kubezyk M., Nonnez G., Morier A. et al., 2014/12. Amyloid, 21 (4) pp. 225-230. Peer-reviewed.
 
Reversible pseudo-Creutzfeldt-Jakob syndrome related to cerebral dural arteriovenous fistula.
Chahbazian K., Théaudin M., Lehmann P., Sachet M., Adams D., Saliou G., 2014/10. Journal of the American Geriatrics Society, 62 (10) pp. 2024-2026. Peer-reviewed.
 
Risk factors of hematomyelia recurrence and clinical outcome in children with intradural spinal cord arteriovenous malformations.
Saliou G., Tej A., Theaudin M., Tardieu M., Ozanne A., Sachet M., Ducreux D., Deiva K., 2014/07. AJNR. American journal of neuroradiology, 35 (7) pp. 1440-1446. Peer-reviewed.
 
FAP neuropathy and emerging treatments.
Adams D., Théaudin M., Cauquil C., Algalarrondo V., Slama M., 2014/03. Current neurology and neuroscience reports, 14 (3) p. 435. Peer-reviewed.
 
Practical Guide to Neurovascular Emergencies
Saliou Guillaume, Theaudin Marie, Join-Lambert Vincent Claire, Souillard-Scemama Raphaelle, 2014. 192, Springer.
 
Sudden loss of consciousness during a flight
Saliou G., Leblanc P. E., Cauquil C., Theaudin M., Ract C., Ducreux D., 2014. Cerebrovasc Dis, 37 (6) pp. 470-1. Peer-reviewed.
 
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy.
Lozeron P., Théaudin M., Mincheva Z., Ducot B., Lacroix C., Adams D., French Network for FAP (CORNAMYL), 2013/12. European journal of neurology, 20 (12) pp. 1539-1545. Peer-reviewed.
 
Atteintes oculaires des neuropathies amyloïdes héréditaires liées à la transthyrétine [Ocular involvement in familial amyloid polyneuropathy]
Rousseau A., Kaswin G., Adams D., Cauquil C., Théaudin M., Mincheva Z., M'garrech M., Labetoulle M., Barreau E., 2013/11. Journal francais d'ophtalmologie, 36 (9) pp. 779-788. Peer-reviewed.
 
Vasculitis neuropathy mimicking lower limb mono-radiculopathy: a study and follow-up of 8 cases.
Lozeron P., Lacroix C., Michon M., Theaudin M., Petit Lacour M.C., Denier C., Adams D., 2013/10. Internal and emergency medicine, 8 (7) pp. 601-609. Peer-reviewed.
 
An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy associated with a novel transthyretin mutation.
Lozeron P., Lacroix C., Theaudin M., Richer A., Gugenheim M., Adams D., Misrahi M., 2013/09. Amyloid, 20 (3) pp. 188-192. Peer-reviewed.
 
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
Yeung J., Cauquil C., Saliou G., Nasser G., Rostomashvili S., Adams D., Théaudin M., 2013/05/07. Neurology, 80 (19) pp. 1812-1813. Peer-reviewed.
 
Immunological hallmarks of JC virus replication in multiple sclerosis patients on long-term natalizumab therapy.
Hendel-Chavez H., de Goër de Herve M.G., Giannesini C., Mazet A.A., Papeix C., Louapre C., Chardain A., Boutarfa N., Théaudin M., Adams D. et al., 2013/05. Journal of virology, 87 (10) pp. 6055-6059. Peer-reviewed.
 
A correlation between fractional anisotropy variations and clinical recovery in spinal cord infarctions.
Théaudin M., Saliou G., Denier C., Adams D., Ducreux D., 2013/04. Journal of neuroimaging : official journal of the American Society of Neuroimaging, 23 (2) pp. 256-258. Peer-reviewed.
 
Neuropathies amyloïdes héréditaires: aspects thérapeutiques [Familial amyloid polyneuropathies: therapeutic issues]
Adams D., Cauquil C., Théaudin M., 2012/10. Bulletin de l'Academie nationale de medecine, 196 (7) pp. 1333-45; discussion 1345-7. Peer-reviewed.
 
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Théaudin M., Saliou G., Ducot B., Deiva K., Denier C., Adams D., Ducreux D., 2012/10. Neuroradiology, 54 (10) pp. 1171-1178. Peer-reviewed.
 
Cortical border-zone infarcts: clinical features, causes and outcome.
Joinlambert C., Saliou G., Flamand-Roze C., Masnou P., Sarov M., Souillard R., Saliou-Théaudin M., Guedj T., Assayag P., Ducreux D. et al., 2012/08. Journal of neurology, neurosurgery, and psychiatry, 83 (8) pp. 771-775. Peer-reviewed.
 
Regional difference and similarity of familial amyloidosis with polyneuropathy in France.
Adams D., Lozeron P., Theaudin M., Mincheva Z., Cauquil C., Adam C., Signate A., Vial C., Maisonobe T., Delmont E. et al., 2012/06. Amyloid, 19 Suppl 1 pp. 61-64. Peer-reviewed.
 
External carotid artery branches involvement in reversible cerebral vasoconstriction syndrome.
Melki E., Denier C., Théaudin-Saliou M., Sachet M., Ducreux D., Saliou G., 2012/02/15. Journal of the neurological sciences, 313 (1-2) pp. 46-47. Peer-reviewed.
 
Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study.
Théaudin M., Lozeron P., Lacroix C., Chrétien P., Ducot B., Denier C., Adams D., 2011/12. Revue neurologique, 167 (12) pp. 897-904. Peer-reviewed.
 
Varied patterns of inaugural light-chain (AL) amyloid polyneuropathy: a monocentric study of 24 patients.
Adams D., Lozeron P., Theaudin M., Denier C., Fagniez O., Rerat K., Signate A., Corcia P., Lacroix C., 2011/06. Amyloid, 18 Suppl 1 pp. 98-100. Peer-reviewed.
 
Guide pratique des urgences neurovasculaires
Saliou Guillaume, Théaudin Marie, Vincent Claire Join-Lambert, Souillard-Scemama Raphaëlle, 2011., Springer Paris.
 
Nouveautés dans le diagnostic et le traitement des neuropathies périphériques liées à l'amylose AL et au syndrome POEMS [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome]
Adams D., Lozeron P., Theaudin M., Ribrag V., Bourhis J.H., Lacroix C., 2011/01. Revue neurologique, 167 (1) pp. 57-63. Peer-reviewed.
 
Watershed infarctions are more prone than other cortical infarcts to cause early-onset seizures.
Denier C., Masnou P., Mapoure Y., Souillard-Scemama R., Guedj T., Théaudin M., Fagniez O., Join-Lambert C., Lozeron P., Ducot B. et al., 2010/10. Archives of neurology, 67 (10) pp. 1219-1223. Peer-reviewed.
 
Should decompressive surgery be performed in malignant cerebral venous thrombosis?: a series of 12 patients.
Théaudin M., Crassard I., Bresson D., Saliou G., Favrole P., Vahedi K., Denier C., Bousser M.G., 2010/04. Stroke, 41 (4) pp. 727-731. Peer-reviewed.
 
[Acute CSF changes in the mesencephalon aqueduct after subarachnoid hemorrhage as measured by PC-MRI]
Saliou G., Baledent O., Lehmann P., Paradot G., Gondry-Jouet C., Bouzerar R., Devisme G., Theaudin M., Deramond H., Le Gars D. et al., 2009/03. J Neuroradiol, 36 (1) pp. 41-7. Peer-reviewed.
 
Lewis-Sumner syndrome and Tangier disease.
Théaudin M., Couvert P., Fournier E., Bouige D., Bruckert E., Perrotte P., Vaschalde Y., Maisonobe T., Bonnefont-Rousselot D., Carrié A. et al., 2008/07. Archives of neurology, 65 (7) pp. 968-970. Peer-reviewed.
 
Cervico-brachial neuralgia caused by spontaneous resorption of ligamentum flavum calcification.
Saliou G., Théaudin M., Grados F., Clavel G., Lehmann P., Rutgers D.R., Vallée J.N., 2008/01. Rheumatology (Oxford, England), 47 (1) pp. 106-107. Peer-reviewed.
 
Dural carotid-cavernous fistula: relationship between evolution of clinical symptoms and venous drainage changes.
Théaudin M., Chapot R., Vahedi K., Bousser M.G., 2008. Cerebrovascular diseases, 25 (4) pp. 382-384. Peer-reviewed.
 
Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?
Williams A., Piaton G., Aigrot M.S., Belhadi A., Théaudin M., Petermann F., Thomas J.L., Zalc B., Lubetzki C., 2007/10. Brain, 130 (Pt 10) pp. 2554-2565. Peer-reviewed.
 
Recanalization of cerebral venous thrombosis within 24 hours: a case report.
Vanden Abeele B., Saliou G., Lehmann P., Théaudin M., Kocheida E.M., Bonnaire B., Vallée J.N., 2007/07/10. Neurology, 69 (2) p. 221. Peer-reviewed.
 
Diagnosis and treatment of dural carotid-cavernous fistulas: a consecutive series of 27 patients.
Théaudin M., Saint-Maurice J.P., Chapot R., Vahedi K., Mazighi M., Vignal C., Saliou G., Stapf C., Bousser M.G., Houdart E., 2007/02. Journal of neurology, neurosurgery, and psychiatry, 78 (2) pp. 174-179. Peer-reviewed.
 
Toxoplasmose oculaire extensive. Conduite diagnostique et thérapeutique [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management]
Theaudin M., Bodaghi B., Cassoux N., Romand S., Le Mer Y., Lemaitre C., Fardeau C., Thulliez P., LeHoang P., 2003/11. Journal francais d'ophtalmologie, 26 (9) pp. 921-927. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University